Search Results - Kent, Emma

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel

    Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel by Facey, Karen M., Espin, Jaime, Kent, Emma, Link, Angèl, Nicod, Elena, O’Leary, Aisling, Xoxi, Entela, van de Vijver, Inneke, Zaremba, Anna, Benisheva, Tatyana, Vagoras, Andrius, Upadhyaya, Sheela

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian can... by González Martín, Antonio, Oza, Amit M., Embleton, Andrew C., Pfisterer, Jacobus, Ledermann, Jonathan A., Pujade-Lauraine, Eric, Kristensen, Gunnar, Bertrand, Monique A., Beale, Philip, Cervantes, Andrés, Kent, Emma, Kaplan, Richard S., Parmar, Mahesh K.B., Scotto, Nana, Perren, Timothy J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma

    Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma by Karagiannis, Panagiotis, Villanova, Federica, Josephs, Debra H, Correa, Isabel, Van Hemelrijck, Mieke, Hobbs, Carl, Saul, Louise, Egbuniwe, Isioma U, Tosi, Isabella, Ilieva, Kristina M, Kent, Emma, Calonje, Eduardo, Harries, Mark, Fentiman, Ian, Taylor-Papadimitriou, Joyce, Burchell, Joy, Spicer, James F, Lacy, Katie E, Nestle, Frank O, Karagiannis, Sophia N

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene

    Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene by Dicks, Ed, Song, Honglin, Ramus, Susan J., Oudenhove, Elke Van, Tyrer, Jonathan P., Intermaggio, Maria P., Kar, Siddhartha, Harrington, Patricia, Bowtell, David D., Group, AOCS Study, Cicek, Mine S., Cunningham, Julie M., Fridley, Brooke L., Alsop, Jennifer, Jimenez-Linan, Mercedes, Piskorz, Anna, Goranova, Teodora, Kent, Emma, Siddiqui, Nadeem, Paul, James, Crawford, Robin, Poblete, Samantha, Lele, Shashi, Sucheston-Campbell, Lara, Moysich, Kirsten B., Sieh, Weiva, McGuire, Valerie, Lester, Jenny, Odunsi, Kunle, Whittemore, Alice S., Bogdanova, Natalia, Dürst, Matthias, Hillemanns, Peter, Karlan, Beth Y., Gentry-Maharaj, Aleksandra, Menon, Usha, Tischkowitz, Marc, Levine, Douglas, Brenton, James D., Dörk, Thilo, Goode, Ellen L., Gayther, Simon A., Pharoah, D.P. Paul

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: